Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06334731
What this trial is testing

Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

Who this might be right for
COVID-19
Methodist Health System 400
Not applicableStudy completedNCT04750330
What this trial is testing

Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection

Who this might be right for
Covid19
Maastricht University 394
Not applicableStudy completedNCT04930965
What this trial is testing

Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate

Who this might be right for
Covid19Vaccine Refusal
Tulane University 56
Post-approval studies (Phase 4)Study completedNCT05142319
What this trial is testing

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]

Who this might be right for
COVID-19
Tan Tock Seng Hospital 326
Not applicableStudy completedNCT04400877
What this trial is testing

Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic

Who this might be right for
COVID-19Venous ThromboembolismPulmonary Embolism+2 more
University Hospital, Linkoeping 7,795
Large-scale testing (Phase 3)WithdrawnNCT04349228
What this trial is testing

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals

Who this might be right for
COVID19Sars-CoV2Hydroxychloroquine+2 more
Abderrahmane Mami Hospital
Not applicableStudy completedNCT06528145
What this trial is testing

Long Covid (Individuals with Ongoing COVID-19 Symptoms) Ongoing Effects

Who this might be right for
COVID-19 Infection
Ziya Yildiz 70
Early research (Phase 1)Study completedNCT05351437
What this trial is testing

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

Who this might be right for
SARS-CoV-2 Infection
Memo Therapeutics AG 32
Not applicableStudy completedNCT06130345
What this trial is testing

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 15,196,685
Not applicableUnknownNCT06085911
What this trial is testing

RCT Long COVID-19 Rehabilitation

Who this might be right for
RehabilitationPost-Acute COVID-19 SyndromePost-Infectious Disorders
University Hospital of North Norway 60
Large-scale testing (Phase 3)Study completedNCT04546581
What this trial is testing

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Who this might be right for
COVIDCOVID-19SARS-CoV-2+1 more
University of Minnesota 593
Early research (Phase 1)Study completedNCT05181709
What this trial is testing

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

Who this might be right for
SARS-CoV-2
Sean Liu 35
Not applicableStudy completedNCT05222139
What this trial is testing

Monitoring COVID-19 Vaccination Response in Fragile Populations

Who this might be right for
SARS CoV 2 InfectionVaccination; InfectionBreakthrough Infection
University of Bologna 8,894
Not applicableStudy completedNCT04606407
What this trial is testing

Inhaled NO for the Treatment of Viral Pneumonia in Adults

Who this might be right for
Viral PneumoniaNitric OxideRespiratory Disease+4 more
Beyond Air Inc. 40
Not applicableActive Not RecruitingNCT07816471
What this trial is testing

RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsImmunocompromised HostInfluenza+1 more
Hospital Italiano de Buenos Aires 350
Not applicableStudy completedNCT04364711
What this trial is testing

EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19

Who this might be right for
COVID-19SARS-CoV 2
UMC Utrecht 300
Large-scale testing (Phase 3)UnknownNCT05124171
What this trial is testing

Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination

Who this might be right for
COVID-19Vaccine Reaction
Assistance Publique - Hôpitaux de Paris 247
Not applicableStudy completedNCT05621239
What this trial is testing

Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People

Who this might be right for
COVID-19
Pfizer 260
Testing effectiveness (Phase 2)Study completedNCT04407507
What this trial is testing

Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms

Who this might be right for
COVID-19
Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V. 66
Not applicableUnknownNCT04817371
What this trial is testing

Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.

Who this might be right for
Covid19
Hopital Foch 192
Next Page